At GE Healthcare, we have made a global commitment to tackling Alzheimer’s disease. Building on the strengths of GE Healthcare’s technology and diagnostic portfolios, we are able to tackle this disease in a number of ways, including imaging agents, scanners and software, to transform the management of Alzheimer’s disease.
GE Healthcare recently established the MIND Coalition, a multidisciplinary, multi-stakeholder body which aims to improve the detection, diagnosis and management of neurodegenerative diseases, with particular emphasis on Alzheimer’s and Parkinson’s diseases. We are committed to making a difference by advancing clinical knowledge, driving new medical innovations, and developing solutions for people living with neurodegenerative disease, including dementia.
As part of this commitment GE Healthcare and the Alzheimer’s Association hosted a panel session titled “Women and Alzheimer’s: A Global Perspective” at this year’s Alzheimer’s Association International Conference (AAIC). Hear more perspectives fromPascale Witz, President and CEO for Medical Diagnostics at GE Healthcare in the accompanying video.